Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Accumulated Depreciation (2024 - 2025)

CG Oncology (CGON) has disclosed Accumulated Depreciation for 1 consecutive years, with $87000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Depreciation changed N/A year-over-year to $87000.0, compared with a TTM value of $87000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $87000.0, changed N/A over the prior year.
  • Accumulated Depreciation was $87000.0 for Q4 2024 at CG Oncology.
  • Across five years, Accumulated Depreciation topped out at $87000.0 in Q4 2024 and bottomed at $87000.0 in Q4 2024.